A “world first” trial of a new drug may have found a way to reverse Alzheimer’s disease, scientists say.
Researchers at University College London have found a “gene silencing” drug cuts the build up of a crucial protein linked to irreversible brain damage by 50%.
The small three-year trial involving 46 patients in the early stages of the disease is the first to show a reduction in the protein called tau in the central nervous system.
